| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,550 | 5,179 | 4,362 | 6,684 | | Cost of Revenue | 5,613 | 3,581 | 2,984 | 4,972 | | | Gross Profit | 2,937 | 1,598 | 1,378 | 1,712 | | | Operating Expenses | | Research Development | 1,813 | 1,730 | 2,077 | 2,404 | | Selling General and Administrative | 3,198 | 3,397 | 3,237 | 3,200 | | Non Recurring | (395) | 395 |
-
| 4,235 | | Others | 45 | 46 | 45 | 46 | | | | Total Operating Expenses | 4,661 | 5,568 |
-
| 9,885 | | | | Operating Income or Loss | (1,724) | (3,970) | (3,981) | (8,173) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 92 | 150 | 208 | 154 | | Earnings Before Interest And Taxes | (1,632) | (3,820) | (3,773) | (8,019) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,632) | (3,820) | (3,773) | (8,019) | | Income Tax Expense | (791) | (1,897) | (1,340) | (1,962) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (841) | (1,923) | (2,433) | (6,057) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (841) | (1,923) | (2,433) | (6,057) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($841) | ($1,923) | ($2,433) | ($6,057) |
|
0.51% Nasdaq 
0.14 (2.19%) 
Income Statement
